← All Sponsors

SPONSOR

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Total Trials

15

Recruiting

15

Phases

EARLY_Phase 1, Phase 2

Conditions studied: Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian Cancer Observing the Effectiveness of Targeted HER2 ADC Drugs Intrahepatic Cholangiocarcinoma Migraine Microwave Ablation Contrast-enhanced Ultrasound Genetic and Molecular Diagnostics Papillary Thyroid Microcarcinoma Sudden Cardiac Death Otolaryngological Diseases Requiring Mastoidectomy

Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary

Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian Cancer

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Intrahepatic Cholangiocarcinoma

A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area

Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study

Microwave Ablation

Pre-warning Risk Scoring System for Sudden Cardiac Death

Sudden Cardiac Death

AI Recognition of Important Structures in Otolaryngological Surgery

Otolaryngological Diseases Requiring Mastoidectomy

NCT05438667 EARLY_Phase 1

TCR-T Cell Therapy on Advanced Solid Tumors

Pancreatic Cancer

Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer

NCT04992559 Phase 2

A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC

Head and Neck Squamous Cell Carcinomas

Radiomics for Preoperative Jaw Cyst Differentiation

Jawbone Cysitc Lesion

NCT06320301 Phase 2

Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)

Biliary Tract Cancer

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Breast Cancer Invasive

NCT05941338 Phase 2

Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC

Head and Neck Squamous Cell Carcinoma

Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma

Hepatocellular Carcinoma

The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery